Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Oct 10;8(10):e01080.
doi: 10.1002/cti2.1080. eCollection 2019.

γδ T cells in cancer: a small population of lymphocytes with big implications

Affiliations
Review

γδ T cells in cancer: a small population of lymphocytes with big implications

Mathilde Raverdeau et al. Clin Transl Immunology. .

Abstract

γδ T cells are a small population of mostly tissue-resident lymphocytes, with both innate and adaptive properties. These unique features make them particularly attractive candidates for the development of new cellular therapy targeted against tumor development. Nevertheless, γδ T cells may play dual roles in cancer, promoting cancer development on the one hand, while participating in antitumor immunity on the other hand. In mice, γδ T-cell subsets preferentially produce IL-17 or IFN-γ. While antitumor functions of murine γδ T cells can be attributed to IFN-γ+ γδ T cells, recent studies have implicated IL-17+ γδ T cells in tumor growth and metastasis. However, in humans, IL-17-producing γδ T cells are rare and most studies have attributed a protective role to γδ T cells against cancer. In this review, we will present the current knowledge and most recent findings on γδ T-cell functions in mouse models of tumor development and human cancers. We will also discuss their potential as cellular immunotherapy against cancer.

Keywords: CAR T‐cells; DOT cells; antitumor immunity; immunotherapy; tumor progression; γδ T cells.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
γδ T cells express an array of activating receptors for tumor cell recognition. Many of these mechanisms rely on the upregulation of stress ligands by tumor cells, including MICA/B (humans), Rae‐1/H‐60 (mouse) and ULBPs. γδ T cells also display an NK‐like phenotype in their expression of NCRs (NKp30, NKp44 and NKp46), particularly following activation. LFA‐1, lymphocyte function‐associated antigen 1; NKG2D, natural killer group 2 member D; PLZF, promyelocytic leukaemia zinc finger protein; Rae1, retinoic acid early inducible‐1; TCR, T‐cell receptor; TRAIL, TNF‐related apoptosis‐inducing ligand; ULBP, UL16‐binding proteins. * denotes expression on some clones only.
Figure 2
Figure 2
Pro‐ and antitumor effect of γδ T cells. (1) Antitumor immunity of γδ T cells by direct killing of tumor cells via perforin, granzymes, granulysin and cytokines. (2) Vγ5+ γδ T cells induce B‐cell class switching to autoreactive antitumor IgE. (3) IFN‐γ production by γδ T cells promotes the recruitment of NK, Th1 and CTLs and induces the differentiation of antitumor macrophages. Additionally, IFN‐γ enhances the presentation capacities of APCs and MHC I expression by tumor cells, while inhibiting pro‐tumor T helper cells. (4) γδ T cells producing IL‐17 promote angiogenesis and suppress antitumor CTL and Th1 cells. (5) Production of IL‐22 and amphiregulin by γδ T cells induces direct tumor cell proliferation. The dashed line separates mouse and human γδ T cells. γδ T cells depicted in red are the cells with antitumor functions, while γδ T cells depicted in green are the cells that promote tumor growth.

References

    1. Fisch P, Malkovsky M, Braakman E, et al Gamma/delta T cell clones and natural killer cell clones mediate distinct patterns of non‐major histocompatibility complex‐restricted cytolysis. J Exp Med 1990; 171: 1567–1579. - PMC - PubMed
    1. Chitadze G, Oberg HH, Wesch D, et al The ambiguous role of γδ T lymphocytes in antitumor immunity. Trends Immunol 2017; 38: 668–678. - PubMed
    1. Silva‐Santos B, Serre K, Norell H. γδ T cells in cancer. Nat Rev Immunol 2015; 15: 683–691. - PubMed
    1. Munoz‐Ruiz M, Sumaria N, Pennington DJ, et al Thymic determinants of γδ T cell differentiation. Trends Immunol 2017; 38: 336–344. - PubMed
    1. Ravens S, Schultze‐Florey C, Raha S, et al Human γδ T cells are quickly reconstituted after stem‐cell transplantation and show adaptive clonal expansion in response to viral infection. Nat Immunol 2017; 18: 393–401. - PubMed